Consolidation radiotherapy in primary central nervous system lymphomas: Impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 1, 2011, Pages 169-175

  Ferreri, Andrés José María ^a   Verona, Chiara ^a   Politi, Letterio Salvatore ^a   Chiara, Anna ^a   Perna, Lucia ^a   Villa, Eugenio ^a   Reni, Michele ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Brain tumor; Central nervous system lymphoma; Local control; Neurotoxicity; Radiotherapy

Indexed keywords

BRAIN TUMORS; CENTRAL NERVOUS SYSTEM LYMPHOMA; CENTRAL NERVOUS SYSTEMS; COMPUTED TOMOGRAPHY; FAILURE-FREE SURVIVAL; HIGH DOSE; IRRADIATION DOSE; LOCAL CONTROL; NEUROTOXICITY; OVERALL SURVIVAL; RADIATION FIELD; RADIATION PARAMETERS; RELAPSE RATES; TREATMENT PLANNING; TUMOR BED; WHOLE-BRAIN IRRADIATION;

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; IRRADIATION; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; RATING; TUMORS;

DISEASE CONTROL;

CYTARABINE; IDARUBICIN; METHOTREXATE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RELAPSE; RISK REDUCTION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROCARBAZINE; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; VINCRISTINE;

EID: 79954420471     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.066     Document Type: Article

References (16)

1. A.J. Ferreri, L.E. Abrey, and J.Y. Blay Summary statement on primary central nervous system lymphomas from the Eighth International Conference On Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002 J Clin Oncol 21 2003 2407 2414 (Pubitemid 46621879)
2. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
3. Y. Shibamoto, N. Hayabuchi, and J. Hiratsuka Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation Cancer 97 2003 128 133 (Pubitemid 36033872)
4. E.M. Bessell, A. Lopez-Guillermo, and S. Villa Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments J Clin Oncol 20 2002 231 236 (Pubitemid 34032616)
5. M. Reni, A.J. Ferreri, and N. Guha-Thakurta Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate Int J Radiat Oncol Biol Phys 51 2001 419 425 (Pubitemid 32884287)
6. G.D. Shah, J. Yahalom, and D.D. Correa Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma J Clin Oncol 25 2007 4730 4735 (Pubitemid 350086474)
7. A.J. Ferreri, J.Y. Blay, and M. Reni Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience J Clin Oncol 21 2003 266 272 (Pubitemid 46606155)
8. A.J. Ferreri, M. Reni, and S. Dell'Oro Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients Oncology 60 2001 134 140 (Pubitemid 32245331)
9. A.J. Ferreri, S. Dell'Oro, and M. Foppoli MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas Neurology 66 2006 1435 1438 (Pubitemid 43739659)
10. A.J. Ferreri, M. Reni, and M. Foppoli High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial Lancet 374 2009 1512 1520
11. M. Reni, and A.J. Ferreri Is withdrawal of consolidation radiotherapy an evidence-based strategy in primary central nervous system lymphomas? J Clin Oncol 22 2004 1165 1167 author reply 1167-1168
12. L.E. Abrey, L.M. DeAngelis, and J. Yahalom Long-term survival in primary CNS lymphoma J Clin Oncol 16 1998 859 863 (Pubitemid 28108717)
13. L.M. DeAngelis, W. Seiferheld, and S.C. Schold Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10 J Clin Oncol 20 2002 4643 4648 (Pubitemid 36025280)
14. L.E. Abrey, J. Yahalom, and L.M. DeAngelis Treatment for primary CNS lymphoma: The next step J Clin Oncol 18 2000 3144 3150
15. D.D. Correa, M. Rocco-Donovan, and L.M. DeAngelis Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy J Neurooncol 91 2009 315 321
16. R. Lai, M.K. Rosenblum, and L.M. DeAngelis Primary CNS lymphoma: A whole-brain disease? Neurology 59 2002 1557 1562 (Pubitemid 35387062)